Clinical trials for thymic tumors
Clinical trials for thymic tumors
May 24 @ 09:30 - 10:30 EDT
We invite patients with thymic epithelial tumors and caregivers for a webinar
Clinical trials for thymic tumors
May 24, 2024 (Friday), 9:30 AM EDT/3:30 PM CET
We will discuss ongoing clinical trials for thymic epithelial tumors (TETs). We have three speakers who will present on ongoing clinical trials: RELEVANT (a study involving carboplatin, paclitaxel, and ramucirumab as the first-line treatment for thymic carcinoma), Sacituzumab Govitecan in TETs, and RADIORYTHMIC (a randomized adjuvant radiotherapy trial in thymoma). Each speaker will deliver a 10-15 min presentation, followed by Q&A for about 20 min.
Moderator: Dr. Chul Kim, Medical Oncologist
Speakers:
- Dr. Claudia Proto, Medical Oncologist
- Dr. Jennifer Marks, Medical Oncologist
- Dr. Clemence Basse, Medical Oncologist
CLICK HERE TO REGISTER
REGISTRATION IS FREE BUT REQUIRED
We suggest installing a Zoom platform before the webinar.
Note:
The webinar will be recorded and published on the ITMIG website. If you do not want to be recognized, please do not turn on the camera and enter your full name when connecting to the meeting.
